FDA Approves First Generic Versions of Ambien (Zolpidem Tartrate) for the Treatment of Insomnia
The following 13 manufacturers have received FDA approval for zolpidem tartrate tablets: Mylan Pharmaceuticals Inc., TEVA Pharmaceuticals USA, Roxane Laboratories Inc., Watson Laboratories Inc., Ranbaxy Laboratories Ltd., Dr. Reddy's Laboratories Ltd., Apotex Inc., Synthon Pharmaceuticals Inc., Genpharm Inc., Mutual Pharmaceutical Company Inc., Caraco Pharmaceutical Laboratories Ltd., Carlsbad Technology Inc., and Lek Pharmaceuticals. (Source: Food and Drug Administration)
FTC Says Firms Failed to Report Drug Patent Pact
The Federal Trade Commission notified a trio of drug makers it believes their failure to inform antitrust authorities of patent infringement deals involving Sanofi's Ambien CR was illegal. (Source: WSJ.com: Health)
